API

FAVIPIRAVIR is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2.

Products still subject to third-party patent protection might be available solely for R&D purposes.

MIRABEGRON, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to antimuscarinic medication.

Products still subject to third-party patent protection might be available solely for R&D purposes.

EDOXABAN TOSYLATE is an anticoagulant medication and a direct factor Xa inhibitor.

Products still subject to third-party patent protection might be available solely for R&D purposes.

ALITRETINOINE, or 9-cis-retinoic acid, is a form of vitamin A. It is also used in medicine as an antineoplastic (anti-cancer) agent developed by Ligand Pharmaceuticals. It is a first generation retinoid.

Products still subject to third-party patent protection might be available solely for R&D purposes.